Bacterial and fungal superinfections in critically ill patients with COVID-19 – Intensive Care Medicine Commentary on Twitter Bacterial/fungal superinfections in critically ill #COVID19 pts: true prevalence still elusive. Underestimation of late superinfection risk may occur in #ICU; confounding factors also hamper identification of most frequently associated bacteria #COVIDFOAM https://t.co/iDAyOwYekr pic.twitter.com/Z7N4V7tc7q — Intens Care Med […]
The post Bacterial and fungal superinfections in critically ill patients with COVID-19 appeared first on Links Medicus.
Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial – JAMA Internal Medicine Invited Commentary: Immune Stimulation With Recombinant Human Granulocyte Colony–Stimulating Factor for Coronavirus Disease 2019 (COVID-19)—Beware of Blind Spots Commentary on Twitter Preliminary findings from a randomized clinical trial suggest that […]
The post Preliminary randomized trial evaluated recombinant human granulocyte colony–stimulating factor for patients with COVID-19 and lymphopenia appeared first on Links Medicus.
COVID-19 and Pneumothorax: A Multicentre Retrospective Case Series – European Respiratory Journal Commentary: Another possible COVID complication: ‘Punctured lung’ – CIDRAP
The post COVID-19 and pneumothorax: A multicenter retrospective case series appeared first on Links Medicus.
NSAIDs like ibuprofen not tied to severe COVID-19, death – CIDRAP Original Study: Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study – PLOS Medicine Related: The case of ibuprofen: Evidence of huge impact of COVID-19 misinformation when coming from credible sources – Universitat […]
The post NSAIDs like ibuprofen not tied to severe COVID-19, death appeared first on Links Medicus.
Cochrane evidence on COVID-19: a round-up – Evidently Cochrane
The post Cochrane evidence on COVID-19: a round-up appeared first on Links Medicus.
High-Flow Oxygen with Capping or Suctioning for Tracheostomy Decannulation – New England Journal of Medicine Commentary on Twitter New insigths in tracheostomy decannulation. A great pleasure to participate on this study leaded by Gonzalo Hernandez. High-Flow Oxygen with Capping or Suctioning for Tracheostomy Decannulation | NEJM https://t.co/103vhwWlvq @vallhebron @NEJM pic.twitter.com/DzyJSAgn1F — Oriol Roca (@oriolrocag) […]
The post [Abstract Only] Randomized trial on strategies for tracheostomy decannulation appeared first on Links Medicus.
Why COVID-19 is more deadly in people with obesity—even if they’re young – Science
The post Why COVID-19 is more deadly in people with obesity—even if they’re young appeared first on Links Medicus.
Clinical Outcomes in Young US Adults Hospitalized With COVID-19 – JAMA Internal Medicine Editorial: Regardless of Age, Obesity and Hypertension Increase Risks With COVID-19 Commentary: Obesity greatest risk factor for young adults with COVID-19 – MedicalXpress Commentary on Twitter 18 to 34 years old #COVID19 hospitalized outcomes: ✔️21% intensive care, ✔️10% mechanical ventilation✔️2.7% died.✔️Morbid […]
The post Clinical outcomes in young adults hospitalized with COVID-19 appeared first on Links Medicus.
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score – The BMJ Commentaries: Discovery of four COVID-19 risk groups helps guide treatment – University of Edinburgh AND Expert reaction to a study looking at predicting the risk of death in […]
The post New easy-to-use score for predicting risk of death in patients hospitalized with Covid-19 appeared first on Links Medicus.
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis – New England Journal of Medicine Commentary on Twitter Original Article: Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (WILLOW Trial) #ERScongress — NEJM (@NEJM) September 7, 2020
The post #ERScongress – [Abstract Only] Phase 2 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis appeared first on Links Medicus.